跳至主要内容
临床试验/NCT02417116
NCT02417116已完成不适用

Tear Osmolarity Clinical Utility in Dry Eye Disease

Aston University8 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2015年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
8
主要终点
Osmolarity change

研究概览

简要总结

Millions of people suffer from dry eye disease, causing symptoms such as redness, burning, feeling of sand or grit in the eye and light sensitivity. Dry eye disease occurs when your eyes do not produce enough tears or produce poor quality tears. This can happen for a number of reasons, including aging, hormonal changes in women and side effects of diseases or medications.

It is now possible to objectively measure the degree of dry eye disease by collecting a tiny sample of tears from the corner of the eye and then measuring the amount of salt in the tears (termed osmolarity). We aim to establish the overall levels of raised and normal tear osmolarity in people presenting to the eye clinic with complaints of dry eye, and relate this to other factors such as symptoms, topical and nutritional medication and dry eye treatment.

详细描述

This study will investigate the efficacy of two treatment non-pharmaceutical therapies (tear drop alone, tear drop combined with omega 3 nutritional supplement and warm compresses) for dry eye reporting patients against a control (saline) over a 3 month period. A relatively new clinical measure (osmolarity) will be performed alongside traditional tear film volume, tear film stability, gland integrity and ocular surface damage measures to determine how this influences symptomatic complaints.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Dry Eye Symptoms SPEED >8

排除标准

  • Unable to participate in 90 days therapy
  • Allergic to therapy
  • On medication known to affect ocular surface / tear film
  • Had ocular trauma, infection or surgery
  • Diagnosed with a medical condition known to affect ocular surface / tear film

研究组 & 干预措施

Control

Placebo Comparator

Minims Saline (Preservative Free) lubricant eye drops - daily for 90 days

干预措施: Saline (Other)

Hypromellose - standard treatment

Active Comparator

Tear Supplement: Hypromellose 0.3% eye drops - daily for 90 days

干预措施: Tear supplement (Other)

Combination treatment

Active Comparator

Tear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days;

干预措施: Tear supplement 2 (Other)

Combination treatment

Active Comparator

Tear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days;

干预措施: Omega 3 nutrition supplement (Dietary Supplement)

Combination treatment

Active Comparator

Tear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days;

干预措施: Eye bag (Device)

结局指标

主要结局

Osmolarity change

时间窗: 3 months

Salt balance in tears measured with the Tearlab

次要结局

  • Tear break-up time change(3 months)
  • Corneal staining change(3 months)
  • Tear Meniscus Height(3 months)
  • SPEED Questionnaire change(3 months)
  • Meibomian gland change(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

Tear Osmolarity Clinical Utility in Dry Eye Disease | 临床试验